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Abstract- Bee declines have been associated with various stressors including pesticides and 1 
pathogens. We separately exposed immune-challenged adult worker honey bees (Apis mellifera 2 
L.) to two neonicotinoid pesticides, thiamethoxam (10 ppb) and imidacloprid (102 ppb), by 3 
dietary delivery. We found that whereas neonicotinoid exposure weakly affected transcriptional 4 
responses of antimicrobial genes, it did not detectably affect the physiological antimicrobial 5 
response as measured by a lytic clearance assay of haemolymph. Our findings add to the 6 
evidence that transcriptional responses in immune-related genes are not yet reliable indicators of 7 
pesticide impacts on bee health, which suggests caution in their future use as biomarkers in 8 
pesticide risk assessment. 9 
 10 
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1. INTRODUCTION 13 
There is widespread concern over losses of managed honey bees (Apis mellifera L.) but 14 
appropriate responses are unclear because a complex of multiple stressors is likely to be 15 
responsible for the observed decline in bee health (Potts et al. 2010). Therefore recent studies 16 
have been conducted in an effort to investigate the potential interactions among stressors and 17 
their effects on various biological systems of honey bees. In particular, there is growing interest 18 
in the interactive effects of pesticide exposure and pathogen infection in bees (reviewed by 19 
Collison et al. 2016). The European Food Safety Authority (EFSA) Panel on Plant Protection 20 
Products and their Residues (PPR) recently recommended that further work is required to 21 
identify the molecular basis of interactions between exposure to pesticides and the range of 22 
diseases in the honey bee (EFSA 2012). Further, EFSA recommended the development of 23 
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physiological and molecular biomarkers as diagnostic tools that could be valuable in improving 1 
risk assessment procedures for determining the effects of pesticides on bees. To better 2 
understand the mechanisms underlying disease-pesticide interactions, recent studies have been 3 
conducted in an effort to investigate the effects of pesticide exposure on bee immunocompetence 4 
(the ability to mount an immune response), with particular focus on the neonicotinoid pesticides, 5 
which have until recently been widely used in the protection of bee-attractive crops such as 6 
oilseed rape (Brassica napus L.).  7 
The immune response in individual honey bees consists primarily of cellular responses, such as 8 
phagocytosis and encapsulation, and humoral responses via the prophenoloxidase cascade 9 
(leading to melanisation) and antimicrobial effectors (Evans et al. 2006). The expression of some 10 
genes related to these immune processes has been found to change following neonicotinoid 11 
exposure, but with no apparent consistency. For example, dietary exposure to imidacloprid led to 12 
increased transcription of the antimicrobial effector abaecin in larval honey bees in one study 13 
(Derecka et al. 2013), but not in another (Gregorc et al. 2012).  In adult honey bees, by contrast, 14 
neonicotinoid exposure reduced transcription in a different antimicrobial effector, apidaecin (Di 15 
Prisco et al. 2013). Neonicotinoid exposure also causes detectable effects at the physiological 16 
level (Brandt et al. 2016), but again with little apparent consistency (Alaux et al. 2010a). Overall, 17 
therefore, it remains unclear whether neonicotinoid-induced changes in the transcription of 18 
immune genes consistently indicate the levels of immunocompetence that are realised at the 19 
physiological level. Previously, few studies have been conducted to test for these corresponding 20 
effects at both the molecular and the physiological level using both a common exposure scenario 21 
and common immune-related endpoints. Consequently, the extent to which the different 22 
components of the immune response react in concert to neonicotinoid exposure has been unclear. 23 
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Potentially, some of the non-correspondence between gene expression and physiological 1 
responses may have arisen because the studies to date have collected measurements at only a 2 
single sampling point in time, but insect immune studies have demonstrated the importance of 3 
temporality in the response to immune challenge (e.g. Gätschenberger et al. 2013, Korner and 4 
Schmid-Hempel 2004, Riddell et al. 2011). In summary, there is a need to investigate how 5 
neonicotinoid pesticides affect immunocompetence in honey bees and whether such an impact 6 
can be reliably detected by examination of molecular responses. 7 
To begin to address this need, we investigated the effect of dietary neonicotinoids on the 8 
antimicrobial peptide (AMP) component of the honey bee immune response. We carried out a 9 
series of laboratory experiments investigating temporal correspondences between changes in 10 
gene expression and measures of physiological AMP activity following exposure to either 11 
imidacloprid or thiamethoxam. Besides testing the impact of these neonicotinoids on 12 
physiological indicators of immunocompetence, our study enabled us to evaluate gene 13 
expression as a biomarker of pesticide effects on bee health.   14 
We investigated the effects of two neonicotinoid insecticides that have been widely used in crop 15 
protection: imidacloprid and thiamethoxam. In Europe and North America, imidacloprid has 16 
been replaced in normal agricultural practice by other neonicotinoids, such as thiamethoxam. 17 
Imidacloprid is nevertheless of interest because it has been the most commonly tested subject in 18 
ecotoxicological investigations of neonicotinoid impacts on bees. For our investigation, we 19 
tested the effect of a dietary concentration (102 parts per billion, ppb) that is much higher than 20 
environmentally realistic levels (<10 ppb), because we wanted to improve the chance of 21 
detecting the response to intoxication. By contrast, in our experiment on thiamethoxam, we used 22 
a dietary dose (10 ppb) that exposed bees to environmentally realistic residue levels (e.g 11 ppb 23 
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in nectar observed by Stoner and Eitzer 2012) as any findings made relative to this dose may 1 
have greater ecological relevance. 2 
Each study was designed as a fully factorial experiment in which two levels of the pesticide 3 
(absent, present) were combined with three levels of immune-challenge (see below). Our 4 
approach principally aimed to both elucidate the effects of pesticide exposure on immune 5 
responses and to test the correspondence of molecular and physiological immune endpoints. We 6 
did not set out to establish dose-dependent effects or to determine threshold levels of toxicity 7 
(e.g. NOECs). 8 
In order to stimulate the immune system of honey bees experimentally, we employed an artificial 9 
immune challenge via an injection with lipopolysaccharides (LPS) from Escherichia coli to 10 
mimic a bacterial-like infection. This approach was adopted to standardise the stimulus and to 11 
avoid the variation inherent in using a real pathogen, which can be logistically difficult to 12 
control. The present study, therefore, does not aim to investigate the biological mechanisms 13 
associated with any specific natural infection, but instead seeks to understand better the 14 
fundamental relationships between the temporal dynamics of transcriptional and physiological 15 
changes using a well-established method for insect immune studies. 16 
2. MATERIALS AND METHODS 17 
We exposed newly emerged adult worker honey bees to either un-dosed control or 18 
neonicotinoid-spiked sucrose feeders and imposed an immune challenge after five days of 19 
experimental feeding. While maintaining bees on the same dietary treatment, we collected 20 
samples for immune-related assays over the remainder of the experimental period. In separate 21 
experiments, sample collection followed either a short time course of between 2 h and 48 h post 22 
immune challenge (PIC) or a longer time course of between 24 h and 168 h (1-7 d) PIC. Samples 23 
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were analysed either for expression levels of six AMP genes or for levels of antimicrobial 1 
activity at a physiological (enzymatic) level (Table I, see also supplementary material for an 2 
overall setup of treatment and sampling combinations). 3 
Across all experiments, individual cages (i.e. and all bees within each cage) were randomly 4 
assigned to a specific sampling time point and sample type at the start of the experiment (with a 5 
total of three cages per treatment/time point combination). No repeated measures were taken, and 6 
all cages contained the same number of bees (10) throughout the experimental period, unless 7 
mortality occurred. Six bees within a cage were pooled for immune measurements (as discussed 8 
below) and each cage was treated as a biological replicate (giving a total of three replicates for 9 
each treatment/time point combination). 10 
For details of data analysis, see supplementary material. 11 
2.1. Honey bee provenance and husbandry 12 
All honey bees were from colonies of British hybrid bees maintained on the home apiary at the 13 
Food and Environment Research Agency, Sand Hutton, York, UK. Visual inspections of these 14 
colonies showed no symptoms of disease or parasitic infection, but baseline levels of pathogens 15 
cannot be ruled out. Further confirmation of pathogen levels (e.g. via PCR) in tested bees or their 16 
colonies was not performed. Brood frames were collected from colonies between April and 17 
September (2013, 2014) and placed in an environmental chamber (34 °C, 60 % relative 18 
humidity, constant darkness; Sanyo Versatile Environmental Test Chamber). Workers were 19 
collected from these frames as they emerged and batches of 10 workers were housed in modified 20 
plastic cages (FK-RD8 clear PET containers; Ambican Ltd, London, UK). Each cage was 21 
designed to allow the bees ad libitum access to a sucrose solution (50 % w/v) through a 22 
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punctured 1.5 mL microcentrifuge tube. Cages were maintained in the environmental chamber 1 
throughout the experimental period (34 °C, 60 % relative humidity, constant darkness). The five 2 
separate experiments described in Table I were each set up on a separate occasion between 3 
August 2013 and June 2014 (no winter bees were used) and each used workers derived from a 4 
single honey bee colony.  5 
2.2. Neonicotinoid exposure 6 
All of our experiments used chronic dietary exposures to sublethal concentrations of one 7 
neonicotinoid, either imidacloprid or thiamethoxam. Stock solutions of neonicotinoids were 8 
made in <0.1% acetone, and used to create the appropriate concentrations. In the imidacloprid 9 
studies, the sucrose feeder syrup was spiked with 125 µg/L (= 102 ppb) imidacloprid (Fluka 10 
Analytical 37894, Sigma-Aldrich, UK). In the thiamethoxam studies, the sucrose was spiked 11 
with 12 µg/L (= 10 ppb) thiamethoxam (Fluka Analytical 37924, Sigma-Aldrich, UK). 12 
Analytical verification of test concentrations was not conducted. All cages were designed to 13 
allow bees to feed ad libitum from the sucrose feeder throughout the experiment. No other food 14 
was provided. Control sucrose contained <0.1% acetone, equivalent to the volume of solvent 15 
used in the neonicotinoid treatments. To quantify feeding rates, the feeder of each cage was 16 
weighed every other day and corrected for evaporation using reference feeders kept in empty 17 
cages. To quantify mortality rates, dead bees were recorded and removed every other day. 18 
2.3. Immune challenge 19 
Bees received one of three injection treatments, with all workers within a cage subjected to the 20 
same treatment under ice-immobilisation (see supplementary material for further details). Bees in 21 
the ‘LPS’ treatment group were injected with a 2 µL aliquot of 0.5 mg/mL LPS (Sigma L2755- 22 
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Lipopolysaccharides from Escherichia coli 0128:B12, Sigma-Aldrich, UK) dissolved in Insect 1 
Ringer’s solution (1:1:1 156 mM NaCl : 3 mM KCl : 2 mM CaCl2). This same LPS 2 
concentration has been widely used previously to elicit an immune response in honey bees 3 
without any acute effects on survival (e.g. Alaux et al. 2012, Köhler et al. 2012, Laughton et al. 4 
2011). Bees in the ‘Ringer’s’ treatment group were injected with 2 µL Insect Ringer’s solution to 5 
control for any effects of the injection process itself. In the ‘naïve’ treatment, bees were ice-6 
immobilised but received no further treatment, which served as the unchallenged control. 7 
2.4. Measurement of gene expression 8 
At the designated time points, bees were placed directly into a freezer at -80 °C and stored until 9 
RNA extraction. Total RNA was extracted from pooled homogenates of six bees (entire bodies) 10 
from a single cage. For each feeding/injection treatment combination and time point, separate 11 
homogenates from three cages were used as biological replicates for real-time quantitative PCR 12 
(qPCR) analysis. Pooling of six bees per replicate homogenate served to minimise between-bee 13 
variation in gene expression profiles. Following RNA extraction, cDNA was synthesised and the 14 
relative expression of six AMP genes (abaecin, apidaecin, defensin-1, defensin-2, hymenoptaecin 15 
and lysozyme-1) was measured using qPCR (supplementary material). 16 
2.5. Measurement of antimicrobial activity 17 
Haemolymph was collected from bees that had first been immobilised on ice. A small slit was 18 
made in the abdominal tergites using sterile dissecting scissors and gentle pressure to the thorax 19 
resulted in a bubble of haemolymph exiting this slit. An aliquot of 2-10 µL of this haemolymph 20 
was collected with a pipette and immediately stored at -20 °C for later analysis. The 21 
antimicrobial activity was separately measured in six individual bees from each single cage and 22 
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the cage mean was used as the biological replicate for statistical analysis. Three cages were 1 
measured for each feeding/injection treatment combination and at each time point. 2 
Antimicrobial activity was measured using a lysozyme clearance assay (Cotter et al. 2008) in 3 
which antimicrobial proteins in the haemolymph lyse the peptidoglycan cell walls of the test 4 
bacteria to produce a clear zone in a bacterial suspension, which is a proxy for relative 5 
antimicrobial activity (a larger zone indicates greater antimicrobial activity). Phosphate buffer 6 
solution (PBS) containing 1% agar was inoculated with 0.2 mg/mL lyophilised Micrococcus 7 
lycodeikticus (M3770; Sigma-Aldrich, UK). 8 mL of this suspension was poured immediately 8 
into a 9 cm-diameter petri dish and left to set. Ten wells (approximately 2 mm diameter) were 9 
bored on each plate. Each haemolymph sample was thawed on ice and a 2 µL aliquot was added 10 
per well. Plates were incubated at 27 °C for 72 h, and the diameters of clearance zones were 11 
measured using digital callipers. 12 
3. RESULTS 13 
3.1. Survival 14 
There were no evident effects of pesticide or injection treatments on honey bee behaviour and 15 
activity. No treatment affected mortality, with the exception that Ringer’s injection increased 16 
mortality in Experiment E (Kruskal-Wallis: χ22df = 7.57, P = 0.023). In the short time course 17 
experiments (2 d), between 2% and 7% of bees died and between 8% and 21% of bees died in 18 
the longer time course experiments (7 d). The mortality rates were uniformly low across the 19 
treatments including the controls, which indicates that the pesticide concentrations and immune 20 
challenges used were essentially sublethal to worker honey bees. 21 
3.2. Gene expression 22 
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In response to LPS injection, four antimicrobial effector genes (abaecin, apidaecin and defensin-1 
1 and hymenoptaecin) were significantly upregulated, but the immune challenge did not alter the 2 
expression of defensin-2 and lysozyme-1 (Table II). A similar temporal pattern of expression 3 
was observed for all four of the upregulated genes, despite between-gene differences in the 4 
magnitude of changes in expression. Increased expression was typically observed as early as 2 h 5 
PIC, increasing to peak expression at between 8 and 24 h PIC, after which the response showed a 6 
gradual decline over the following six days (Fig. 1; see also Fig. S1-S5). 7 
Exposure to imidacloprid was not found to alter expression of any of the six AMP genes tested 8 
across the short or long time course experiments (Table II). 9 
Exposure to thiamethoxam reduced the expression of abaecin dependent on the injection 10 
treatment, but this effect was not seen in the longer time course study (Table II). Reduced 11 
transcription of abaecin was most notable in response to thiamethoxam exposure 24 h post LPS-12 
injection (Fig. 1). Thiamethoxam exposure also had various effects on expression of apidaecin, 13 
hymenoptaecin and lysozyme-1, but these effects were dependent on the time of sampling, and 14 
only observed in the short time course experiment (Table II). Here, increased transcription of 15 
apidaecin was observed following thiamethoxam exposure, most notably at 24 h post LPS-16 
injection (Fig. S1), whilst reduced transcription of hymenoptaecin was observed following 17 
thiamethoxam exposure between 8 and 24 h PIC (Fig. S2) and the effects of thiamethoxam on 18 
lysozyme-1 were transient (Fig. S5). 19 
3.3. Antimicrobial activity 20 
Antimicrobial activity at a physiological (enzymatic) level was significantly increased in 21 
response to LPS injection in a time-dependent manner during both the short and long time course 22 
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experiments (Table II; Fig. 2). Ringer’s injection also induced a response, but to a lesser extent 1 
than in bees injected with LPS (Fig. 2). A peak in activity occurred between 24 and 72 h PIC, 2 
followed by a gradual decline over the following days, and levels typically had not returned to 3 
the baseline levels by the last sampling point 7 d PIC (Fig. 2). 4 
No effects of exposure to either imidacloprid or thiamethoxam were observed on antimicrobial 5 
activity in any of the experiments (Table II) and the temporal dynamics of the response to 6 
injection were virtually identical in bees fed with control sucrose and those exposed to the 7 
neonicotinoids (Fig. 2). 8 
3.4. Sucrose consumption 9 
Consumption of imidacloprid-spiked sucrose was significantly lower than the consumption of 10 
control sucrose in all experiments (Table S2). In general, there were no significant differences in 11 
consumption between bees feeding on control and thiamethoxam-spiked sucrose. The exception 12 
to this was for bees in Experiment A, where there was significantly reduced feeding in the 13 
thiamethoxam treatment (Table S2). Even when reduced feeding was observed in neonicotinoid-14 
treated bees, bees ingested substantial amounts of sucrose (e.g. in Experiment A, mean daily 15 
sucrose consumption in the four days prior to immune challenge for control-fed: 46 ± 3 mg/bee; 16 
for imidacloprid-fed: 38 ± 4 mg/bee; for thiamethoxam-fed bees: 36 ± 2 mg/bee) and consumed 17 
substantial doses of neonicotinoid (3.0 ± 0.3 ng imidacloprid/bee; 2.8 ± 0.2 ng 18 
thiamethoxam/bee). There was no evidence that injection treatment altered sucrose consumption 19 
(all experiments: ANOVA P > 0.05). 20 
4. DISCUSSION 21 
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Four antimicrobial effector genes showed a clear upregulation in response to the artificial 1 
immune challenge. The response to immune challenge differed between the two defensin genes 2 
tested (defensin-1 and defensin-2), which is consistent with previous studies (Evans 2006) and 3 
known differences in the regulation of the two genes (Klaudiny et al. 2005). The lack of a 4 
detectable response by lysozyme-1 is consistent with most of the previous studies of bacterial 5 
infection in honey bees (e.g. Evans 2006, Yang and Cox-Foster 2005). This may reflect the 6 
proposition that lysozymes act by hydrolysing the peptidoglycan cell wall (Gillespie et al. 1997) 7 
and so are more effective against Gram-positive bacteria, which have a thicker peptidoglycan 8 
layer. Therefore, it is perhaps not surprising that lysozyme-1 was not found to be upregulated in 9 
response to the LPS molecules from Gram-negative E.coli in the present study.  10 
The transcriptional changes in AMP genes in response to immune challenge that occurred in our 11 
study probably have functional significance because they were accompanied by increases in 12 
antimicrobial activity at the protein/enzyme level. Wounding by injection alone induced an 13 
antimicrobial response, albeit to a lesser extent than injection with bacterial LPS, which is 14 
consistent with previous studies (Evans et al. 2006, Laughton et al. 2011, Yang and Cox-Foster 15 
2005). The wound-response to injection that we observed may be similar to the response to other 16 
natural wounding events, such as puncturing by Varroa mites (Kanbar and Engels 2003) and 17 
parasitic flies (Core et al. 2012). It is likely that an increased response in transcription of AMP-18 
related genes following wounding is adaptive by allowing the honey bee to pre-emptively induce 19 
its immune system before microbial infection, because most natural wounds will inevitably be 20 
non-sterile (Erler et al. 2011, Kanbar and Engels 2003). 21 
The effects of neonicotinoid exposure on transcriptional responses in the antimicrobial 22 
component of honey bee immunity were weak and inconsistent. Where transcriptional changes 23 
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were observed, they differed between the two neonicotinoid compounds. Generally, expression 1 
was altered in a greater number of the genes tested following exposure to thiamethoxam than to 2 
the much higher exposure to imidacloprid, but even in the case of thiamethoxam the results were 3 
inconsistent because effects differed between the short- and long- time course experiments, even 4 
at equivalent time points. 5 
Neonicotinoid exposure did not affect the physiological activity of the antimicrobial response in 6 
our study as measured by a lytic clearance assay, even when transcriptional changes in AMP 7 
gene expression were observed. Taken together, our findings therefore suggest that the 8 
transcriptional changes in AMP genes due to neonicotinoid exposure that we observed did not 9 
indicate a detrimental impact on bee health through suppressed immunocompetence, contrary to 10 
what has been proposed by others (e.g. Di Prisco et al. 2013). We tentatively speculate that 11 
differential gene expression may fail to cause a correspondingly altered physiological response. 12 
If the insecticide evokes various positive and negative changes in the expression of antimicrobial 13 
genes, overall, the system may be virtually left in balance. For example, we observed that 14 
thiamethoxam both suppressed hymenoptaecin expression and increased apidaecin expression.   15 
Our findings have implications for the future development of molecular biomarkers of bee health 16 
under pesticide and pathogen exposures. There has been recent interest in identifying suitable 17 
molecular biomarkers for pesticide risk assessment on bees (EFSA 2012). However, our findings 18 
do not yet validate the use of the immune-related molecular biomarkers in risk assessment, 19 
principally because we found that enzymatic/protein-level components of honey bee 20 
antimicrobial activity were unaffected by neonicotinoid exposure despite the occurrence of some 21 
temporally coincident, pesticide-induced transcriptional changes in AMP genes. In summary, if 22 
the loci that we studied were to be used as molecular biomarkers, our findings imply that they 23 
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would be overly sensitive indicators of alterations in the physiological capacities of honey bees 1 
to mount an immune response. However, it is unknown whether our findings for neonicotinoids 2 
are typical for other classes of chemical compounds. 3 
We recognise that our findings must be considered with some caveats. First, we conducted a 4 
series of separate experiments on individual honey bee colonies and this may have some bearing 5 
on our conclusions. Specifically, while our findings certainly suggest the potential for differences 6 
in the response of different immune endpoints to pesticide exposure, some of these differences 7 
could result also from between-colony variation in pesticide sensitivity. In the future, further 8 
work could compare transcriptional and physiological responses of honey bees both within a 9 
single colony as well as among a number of colonies, and also within and between seasons. 10 
Second, further research is needed to establish whether the resilience of the response to 11 
simulated immune-stimulus in pesticide-exposed honey bees also arises when they are 12 
challenged by their natural pathogens. We tentatively predict that our findings will generalise to 13 
natural pathogens because of the commonality of responses by several AMP genes under 14 
infection with a broad range of challenges, including honey bee bacterial, fungal and 15 
microsporidian pathogens (Antunez et al. 2009, Evans 2006). In the future, however, only 16 
investigations using natural pathogens can truly assess environmentally relevant impacts of 17 
pesticides on bee health. Finally, our laboratory findings are yet to be generalised to honey bee 18 
colonies under realistic in-hive conditions. Although we detected no functionally significant 19 
impacts on honey bee immunocompetence in laboratory exposures that probably exceed many 20 
environmentally relevant neonicotinoid exposures, we are also tentative in generalising our 21 
findings to bees under field-relevant conditions for three reasons. First, our experimental 22 
exposures were conducted for periods of up to 11 days, whereas realistic in-hive exposures may 23 
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be for longer periods. Second, our laboratory setup did not provide access to a pollen supply and 1 
pollen nutrition has been shown to affect immunocompetence (Alaux et al. 2010b). Third, we 2 
tested only a subset of endpoints and there are many other functionally relevant genes and 3 
enzymes belonging to various pathways in the honey bee immune system. 4 
5. CONCLUSIONS 5 
In summary, our experiments showed an overall clear temporal pattern of AMP gene expression 6 
and physiological activity in response to a bacterial-like infection.  Our principal finding is that 7 
the transcriptional changes in AMP genes following neonicotinoid exposure did not correspond 8 
with immune suppression at the physiological level. If this finding turns out to be general, it 9 
suggests that honey bee immunity may be more resilient to neonicotinoid exposure than 10 
previously thought based on molecular studies only, but this will need further investigation and, 11 
particularly, using honey bees maintained under environmentally realistic conditions. Our 12 
findings begin to enable regulators to better evaluate the potential of gene expression as a 13 
biomarker for bee health. For those genes studied here, bioassays based on gene expression are 14 
not yet reliable indicators of pesticide effects on honey bee immune functioning at a 15 
physiological level. 16 
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FIGURE CAPTIONS 1 
Fig. 1 Gene expression of the AMP gene, abaecin, in response to artificial immune challenge 2 
over time in control-fed (black shapes) and neonicotinoid-exposed (white shapes) bees. Top 3 
plots: Results for exposure to 125 µg/L imidacloprid [Experiments A (left) and D (right)]. 4 
Bottom plots: Results for exposure to 12 µg/L thiamethoxam [Experiments A (left) and E 5 
(right)]. Plots on the left hand side show responses for a period of 2-48 h post immune challenge 6 
(PIC) and plots on the right hand side for a period of 1-7 d PIC. In all plots, shapes indicate 7 
sample means and error bars depict 1 SE. Only upper error bars are shown to simplify the figures 8 
 9 
Fig. 2 Physiological antimicrobial activity to artificial immune challenge over time in control-fed 10 
(black shapes) and neonicotinoid-exposed (white shapes) bees. Top plots: Results for exposure to 11 
125 µg/L imidacloprid [Experiments B (left) and D (right)]. Bottom plots: Results for exposure 12 
to 12 µg/L thiamethoxam [Experiments C (left) and E (right)]. Plots on the left hand side show 13 
responses for a period of 2-48 h post immune challenge (PIC) and plots on the right hand side for 14 
a period of 1-7 d PIC. Note, the y-axis scales differ between plots. In all plots, shapes indicate 15 
sample means and error bars depict 1 SE. Only upper error bars are shown to simplify the figures 16 
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TABLES 1 
Table I Overview of the test substances, sampling time course and endpoints measured in each 2 
of five experiments. Each experiment was performed with newly emerged honey bees from a 3 
single colony. A different colony was used for each experiment. See supplementary material for 4 
an overall setup of treatment and sampling combinations.   5 
 6 
Experimental details 
Experiment 
A 
Experiment 
B 
Experiment 
C 
Experiment 
D 
Experiment 
E 
Pesticides 
tested in each 
experiment1 
Control vs 
125 µg/L 
IMI 
     
Control vs 
12 µg/L 
TMX 
     
Samples taken 
across either 
‘short’ of 
‘long’ time 
course in each 
experiment 
Short time 
course (2-
48 h) 
     
Long time 
course (24-
168 h) 
     
Endpoints 
measured in 
each 
experiment2 
Gene 
expression 
(qPCR) 
     
AMP 
enzymatic 
activity 
     
Total combinations tested 
(total no. of cages in 
parentheses)3 
54 
(162) 
24 
(72) 
24 
(72) 
60 
(180) 
60 
(180) 
IMI = imidacloprid; TMX = thiamethoxam 7 
1 Where both compounds were tested in a single experiment, each compound was tested independently. i.e. cages of 8 
10 bees were exposed to either IMI or TMX, but never to both. Where boxes are left blank, the pesticide of concern 9 
was not tested in the given experiment. 10 
2 Where both gene expression and enzymatic activity were measured in a single experiment, each endpoint was 11 
tested independently. i.e. individual bees were used in samples for either gene expression or enzymatic activity, but 12 
never for both. Where boxes are left blank, the endpoint of concern was not tested in the given experiment. 13 
3 Combinations of pesticide x immune challenge x sampling time point x measurement type. Please refer to 14 
supplementary material for overview of all combinations. Note, the total number of combinations across all 15 
experiments is greater than 180 because control groups were included in all experiments. In all experiments, 3 cages 16 
(replicates) of 10 bees were tested per combination. 17 
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Table II (next page) ANOVA results for all five experiments. Data analysis was only 1 
conducted between samples within a single experiment, but presented below to show all 2 
comparisons/endpoints tested across the five experiments. Variation among treatments 3 
was analysed by factorial ANOVA with injection (immune challenge) treatment, 4 
pesticide treatment and time post immune challenge as fixed effects. ‘Injection’ refers to 5 
comparison between the ‘Ringer’s’ and ‘LPS’ injection groups; this injection 6 
comparison was seen of most biological relevance as it reflected responses only to the 7 
bacterial molecules (albeit artificial), but not to the injection procedure itself. ‘Pesticide’ 8 
refers to comparison between control-fed and pesticide-fed bees (either imidacloprid or 9 
thiamethoxam, depending on the experiment). 10 
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Abaecin Apidaecin Hymenoptaecin Defensin1 Defensin2 Lysozyme1 
AMP enzymatic 
activity 
 Experiment A1 Experiment B2 
S
h
o
rt
  
ti
m
e 
c
o
u
rs
e 
(0
 –
 4
8
 h
) 
IMIDACLOPRID df F P F P F P F P F P F P df F P 
Injection 1 106 <0.001 27.0 <0.001 176 <0.001 30.3 <0.001 2.42 0.126 2.68 0.107 1 18.2 <0.001 
Pesticide 1 1.21 0.278 0.617 0.436 0.051 0.823 4.62 0.036 0.497 0.484 1.04 0.313 1 2.93 0.096 
Time 5 141 <0.001 34.3 <0.001 153 <0.001 28.6 <0.001 1.09 0.377 1.98 0.097 3 160 <0.001 
Injection*Pesticide 1 3.39 0.071 2.79 0.101 5.38 0.024 0.532 0.469 0.187 0.668 0.176 0.676 1 4.12 0.050 
Pesticide*Time 5 0.319 0.899 0.068 0.997 1.41 0.235 0.868 0.509 1.28 0.287 0.876 0.504 3 1.49 0.234 
Injection*Time 5 13.1 <0.001 3.73 0.006 20.3 <0.001 2.39 0.050 0.220 0.952 0.147 0.980 3 6.72 0.001 
Residuals 53             35   
 Experiment A
1 Experiment C2 
S
h
o
rt
 t
im
e 
c
o
u
rs
e 
 
(0
 –
 4
8
 h
) 
THIAMETHOXAM df F P F P F P F P F P F P df F P 
Injection 1 96.8 <0.001 31.3 <0.001 93.3 <0.001 20.6 <0.001 0.489 0.487 0.368 0.547 1 27.8 <0.001 
Pesticide 1 11.5 0.001 21.8 <0.001 47.8 <0.001 3.85 0.055 1.67 0.202 8.60 0.005 1 0.013 0.908 
Time 5 81.6 <0.001 35.4 <0.001 87.0 <0.001 27.3 <0.001 2.66 0.033 5.45 <0.001 3 88.6 <0.001 
Injection*Pesticide 1 10.7 0.002 0.615 0.436 3.31 0.075 0.012 0.915 4.70 0.035 1.62 0.209 1 0.952 0.336 
Pesticide*Time 5 1.87 0.115 3.88 0.005 14.3 <0.001 1.28 0.287 2.24 0.064 6.07 <0.001 3 0.811 0.496 
Injection*Time 5 7.45 <0.001 3.12 0.015 16.1 <0.001 3.13 0.015 2.23 0.065 1.88 0.113 3 9.15 <0.001 
Residuals 52             35     
 Experiment D
2,3 
L
o
n
g
 t
im
e 
c
o
u
rs
e
 
(0
 –
 1
6
8
 h
) 
IMIDACLOPRID df F P F P F P F P F P F P df F P 
Injection 1 25.4 <0.001 48.3 <0.001 14.6 <0.001 - - - - - - 1 119 <0.001 
Pesticide 1 0.022 0.883 2.75 0.106 0.074 0.787 - - - - - - 1 0.134 0.717 
Time 3 16.0 <0.001 13.2 <0.001 9.41 <0.001 - - - - - - 3 42.1 <0.001 
Injection*Pesticide 1 3.38 0.075 0.879 0.355 0.629 0.433 - - - - - - 1 0.105 0.748 
Pesticide*Time 3 1.18 0.334 0.279 0.840 1.23 0.315 - - - - - - 3 1.36 0.272 
Injection*Time 3 0.801 0.502 0.879 0.485 4.90 0.006 - - - - - - 3 6.99 <0.001 
Residuals 34             34   
 Experiment E
2,3 
L
o
n
g
 t
im
e 
co
u
rs
e 
(0
 –
 
1
6
8
 h
) 
THIAMETHOXAM df F P F P F P F P F P F P df F P 
Injection 1 32.9 <0.001 32.2 <0.001 37.0 <0.001 - - - - - - 1 44.3 <0.001 
Pesticide 1 0.989 0.327 0.359 0.554 0.272 0.606 - - - - - - 1 0.039 0.845 
Time 3 13.7 <0.001 15.8 <0.001 15.1 <0.001 - - - - - - 3 35.0 <0.001 
Injection*Pesticide 1 0.25 0.624 1.57 0.219 0.047 0.830 - - - - - - 1 0.088 0.769 
24 
 
Pesticide*Time 3 0.799 0.503 0.199 0.896 1.81 0.164 - - - - - - 3 0.655 0.586 
Injection*Time 3 3.06 0.042 4.29 0.012 2.36 0.090 - - - - - - 3 3.39 0.029 
Residuals 33             33     
1 In Experiment A, where imidacloprid and thiamethoxam treatments were both included within the single experiment, the imidacloprid and thiamethoxam datasets 1 
were analysed separately as we were only interested in the differences between each pesticide and the control-fed bees. Since the control dataset was therefore used in 2 
both analyses, in Experiment A a significant effect was defined by P ≤ 0.025 (in bold), accounting for a Bonferroni correction. 3 
2 Significant effect defined by P ≤ 0.05 (in bold). 4 
3 Expression of the genes Defensin1, Defensin2 and Lysozyme1 was not measured in the long time course experiments (experiments D and E). 5 
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